NOVEMBER 2022LIFE SCIENCES REVIEW5CXO INSIGHTS18Giuliana Vallanti, Director, Development and Global R&D Cell and Gene, Margherita Neri, Vector Process Development Manager, Anna Stornaiuolo, AGC BiologicsLike a Tailored Suite: Producing Customized Viral Vectors that Respond to Market Demands26Dr. Linda Randall, AVP Biologics Manufacturing & Control,Pharmarons Gene TherapyThe Tipping Point for Scalable Manufacturing Processes to Pivot Gene Therapies - from a Hope Into Life-Changing TreatmentsPhilippe Pinton, SVP, Global Head Translational Medicine and Clinical Pharmacology, Ferring PharmaceuticalsProteomics in Health Sciences2422Kinga Bercsenyi, PhD,European Lead for Precision Medicine & Biomarker Solutions, Cerba ResearchWorldwide Patients' Access to Life-Changing TherapiesTISSUE ENGINEERINGCOMPANIES IN EUROPE - 2022TOP 10
< Page 4 | Page 6 >